| Medtronic plc | $126.5b | $102.43 | +1.9% | 4.1M | |
| Edwards Lifesciences Corp | $54.9b | $106.83 | +1.3% | 3.0M | |
| Biogen Inc. Common Stock | $36.8b | $254.61 | +1.2% | 814.5K | |
| Alcon Inc. Ordinary Shares | $35.0b | $74.11 | +3.2% | 2.6M | |
| Zimmer Biomet Holdings, Inc. | $18.5b | $102.92 | -1.3% | 2.0M | |
| Glaukos Corporation | $13.8b | $245.71 | -0.1% | 446.4K | |
| Bausch + Lomb Corporation | $7.2b | $20.87 | -0.2% | 479.7K | |
| Denali Therapeutics Inc. Common Stock | $3.1b | $18.74 | -0.8% | 565.1K | |
| Bioventus Inc. Class A Common Stock | $0.7b | $10.62 | -1.9% | 533.6K | |
| Anteris Technologies Global Corp. Common Stock | $0.5b | $5.42 | -7.6% | 1.0M | |
| BioAge Labs, Inc. Common Stock | $273.5m | $5.46 | -2.1% | 359.3K | |
| Alector, Inc. Common Stock | $228.9m | $2.46 | +4.1% | 1.7M | |
| AC Immune SA | $207.8m | $2.13 | -0.7% | 112.1K | |
| Alpha Cognition Inc. Common Stock | $178.6m | $8.31 | -2.3% | 78.5K | |
| Outlook Therapeutics, Inc. Common Stock | $112.0m | $0.41 | -6.3% | 3.0M | |
| LENZ Therapeutics, Inc. Common Stock | $110.0m | $4.17 | +0.7% | 677.4K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $67.0m | $0.50 | -1.9% | 123.9K | |
| Cognition Therapeutics, Inc. Common Stock | $66.5m | $0.70 | -0.8% | 261.2K | |
| Greenland Mines Ltd. Common Stock | $57.2m | $3.70 | -6.1% | 414.8K | |
| Envoy Medical, Inc. Class A Common Stock | $51.2m | $6.74 | +1.2% | 9.8K | |
| Annovis Bio, Inc. | $46.5m | $0.93 | +8.8% | 2.1M | |
| CervoMed Inc. Common Stock | $23.4m | $1.69 | -8.5% | 623.3K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $17.0m | $0.20 | -2.4% | 2.6M | |
| OSR Health, Inc. Common Stock | $15.7m | $0.11 | 0.0% | N/A | |
| Alzamend Neuro, Inc. Common Stock | $7.0m | $1.26 | -4.2% | 38.6K | |
| FibroBiologics, Inc. Common Stock | $7.0m | $0.94 | -0.1% | 35.0K | |
| Longeveron Inc. Common Stock | $5.7m | $2.45 | -16.5% | 59.2K | |
| 20/20 Biolabs, Inc. Common Stock | $3.0m | $0.20 | -3.1% | 52.5K | |
| HCW Biologics Inc. Common Stock | $2.6m | $0.79 | 0.0% | 22.3K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $2.4m | $1.70 | 0.0% | 18.1K |